Ernst & Young is also a global leader in professional services with some 114,000 people based in 140 countries. Around the world the firm is committed to pursuing the highest levels of integrity, quality, and professionalism in delivering a broad inventory of services to our clients. Our services fall under three broad headings: Assurance and Advisory Business Services (AABS), Transaction Advisory Services (TAS) and Taxation Services. Our 'account-centric' organisational model recognises that many client issues are best addressed by a number of our service lines working together.. Ernst & Young UK comprises approximately 470 partners and 8000 staff. In 2006 UK fee income increased by 20% to £1.13bn whilst staff numbers excluding partners increased by 8% to 7,902. We provided services to 84 of the FTSE 100 companies and 93% of our clients indicated they were satisfied or very satisfied with our service. For the second year running, we qualified for the Per Cent Standard, meaning that we gave more than 1% of our notional pre-tax profits to charity and we ranked 61st in the Business in the Community's Environment Index.. . COMMITMENT TO BIOTECHNOLOGY. For the past 20 years, Ernst &Young has been a leading professional services firm serving the biotechnology industry, thanks to our extensive global network of experienced professionals and our industry-leading annual publication, Beyond Borders: The Global Biotechnology Report.. Now recognised as the industry bible, Ernst & Young's global biotechnology report, Beyond Borders, provides an overview of the latest developments in the global biotechnology sector. Our report demonstrates that on the cusp of its 30th birthday, the biotech industry is maturing rapidly, with solid financial performance and a substantial track record of bringing new products to market. The contents and themes of this report derive from substantial research by our Global Biotechnology Center, and more importantly, from our leading position serving prominent biotechnology companies around the world.. The life sciences industry is widely acknowledged as one of the leading industries in the future global economy, Ernst & Young has helped shape the global life sciences industry since its inception, advising more of its leading companies than any other professional service firm. We advise one third of life sciences companies globally, have a global network of life sciences specialists in 17 European countries, and boast the UK's largest dedicated life sciences team which our Cambridge office forms part of.. We are reporting accountants to companies in respect of their IPOs on AIM, the London Stock Exchange, and NASDAQ, and are experts in providing tax planning advice for companies seeking IPOs including share option planning.. . CONTACTS:. Julian Jenkins (Audit Partner). 01223 557073. Cathy Taylor (Tax Partner). 01223 557090. Simon Gillings (Transaction Support). 01223 557071
Essen BioScience is a world leader in the field of innovative cell-based assays, reagents, instrumentation and custom services for discovery research. Our specialities include phenotypic 'live content' kinetic imaging assays based around IncuCyte Zoom (e.g. angiogenesis, neurite outgrowth, cell migration/invasion, apoptosis etc.) and high throughput automated electrophysiology for ion channel drug discovery and safety (e.g. hERG assays). Our live content imaging solution has been adopted by laboratories across all 10 of the world’s top pharmaceutical companies as well as more than 150 leading biotechnology and academic research institutions.
Selcia Ltd headquartered in Ongar, Essex, UK, is a leading worldwide provider of contract research services. Selcia Discovery provides integrated small molecule drug discovery, including general medicinal chemistry and biology capabilities, applicable across all target classes with a particular strength in three unique and highly synergistic technologies: (1) medicinal chemistry on complex natural products; (2) capillary electrophoresis-based fragment and natural product screening; and (3) peptidyl-prolyl isomerase targets (cyclophilins, FKBPs, Pin1, together called PPIases). Selcia Radiolabelling specialises in GMP radiolabelled API and in 14C custom radiolabelling for metabolism, distribution and environmental fate studies.
No data available
No data available
F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to create bispecific antibodies, where the second binding site is in the constant Fc region of an antibody, offering unprecedented ease in the discovery, development and manufacturing of bispecific antibody products. The strength of the technology and programmes has been leveraged through partnerships with leading biopharmaceutical companies including, AbbVie, Bristol-Myers Squibb, Merck Serono and Boehringer Ingelheim.. . For more information visit https://www.f-star.com
Field Fisher Waterhouse is a UK Top 30 law firm with over 130 partners and over 260 other lawyers offering the full range of legal services. . . Life sciences clients choose to work with us because we have a substantial team of exceptional lawyers, each with their particular specialism, but who at the same time know the major commercial, legal and regulatory issues affecting this industry sector. . . They also appreciate that when we say full service, we really can deliver on all counts, be it advising on regulatory matters, corporate and commercial issues, IP licensing and litigation, competition law issues, compliance with data privacy requirements, complex tax arrangements, trade marks, employment and real estate. . . Through our network of offices in London, Manchester, Brussels, Hamburg and Paris our clients understand that they will get real value from our flexible approach to teamwork and our willingness to shape our structures and way of working to meet their specific needs. . . This commercial attitude, combined with our empowering and down-to earth style, means you can trust us to provide you with the best possible legal solutions. . . One of our key strengths is our focus on industry sectors such as life sciences, with expertise in the pharmaceutical, biotechnology and medical devices industries. . . By pooling our expertise in the life sciences sector across different legal disciplines and our European offices into an industry group, we can provide you with a joined-up approach to your legal issues. It enables us to keep up-to-date with developments in the sector, delivering realistic and practical solutions to our clients' issues. . . Many of our lawyers have a scientific or medical background. This enables us quickly to understand the technology that underpins, and gives value to, our life sciences clients' businesses. . . Our Life Sciences group works with clients at all stages of innovation, from bench to bedside and helps companies to develop and grow their businesses within the strict regulatory requirements that can apply in this sector. During the various stages of growth our lawyers help pharmaceuticals clients with: . regulatory compliance, approval and issues arising with competent authorities . licensing, collaboration and marketing agreements . patent litigation . data protection and privacy . trade mark registration and litigation . clinical trial agreements and regulation . supply, distribution, manufacturing and tooling agreements . corporate finance and M&A . competition & EU regulatory (including REACH) . outsourcing projects and services . real estate, employment and pensions . tax planning and valuation
No data available
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options.
No data available